400-089-6690
最快3分鐘報價熱線
新聞中心
目前我國(guo)中(zhong)(zhong)藥材和中(zhong)(zhong)藥飲片市(shi)場亂象叢(cong)生,假冒偽劣事(shi)件屢見不鮮,嚴重(zhong)影響中(zhong)(zhong)醫(yi)藥聲譽,不但給消費者健康(kang)帶來很(hen)大隱(yin)患(huan),且直接威脅(xie)到我國(guo)中(zhong)(zhong)醫(yi)藥事(shi)業的長(chang)遠發展。
“在國(guo)家加大中(zhong)(zhong)藥材(cai)、中(zhong)(zhong)藥飲片市(shi)(shi)場整(zheng)頓力度(du)(du)的同時,出現了一(yi)些新情況。”劉文偉(wei)認為,規范中(zhong)(zhong)藥材(cai)市(shi)(shi)場關鍵在于源頭把(ba)控,同時要提升優質企業(ye)中(zhong)(zhong)藥飲片市(shi)(shi)場集中(zhong)(zhong)度(du)(du),鼓(gu)勵(li)中(zhong)(zhong)藥飲片企業(ye)根據自(zi)身需(xu)求向中(zhong)(zhong)藥材(cai)種植(zhi)領域(yu)拓(tuo)展。
“要建立(li)(li)質量追溯體系(xi)(xi),重(zhong)點(dian)打(da)擊摻雜、造假行為。”劉文偉委員建議(yi)利用物聯(lian)網等新技術,建立(li)(li)中(zhong)(zhong)(zhong)藥(yao)材、中(zhong)(zhong)(zhong)藥(yao)飲(yin)片(pian)質量追溯系(xi)(xi)統,實現中(zhong)(zhong)(zhong)藥(yao)材、中(zhong)(zhong)(zhong)藥(yao)飲(yin)片(pian)鏈(lian)條式管(guan)理,從(cong)而督促經營者(zhe)注重(zhong)中(zhong)(zhong)(zhong)藥(yao)材質量。同(tong)時(shi)轉變政(zheng)府(fu)職能,打(da)破地(di)方保護(hu)主(zhu)義,從(cong)制度(du)層面(mian)上倒逼各級政(zheng)府(fu)重(zhong)新審視藥(yao)品安(an)全(quan)責任與當地(di)GDP之間(jian)的平衡(heng)關系(xi)(xi)。
免責(ze)申(shen)明:部(bu)分文(wen)章(zhang)圖片轉(zhuan)載自行(xing)業網站文(wen)章(zhang)分享,未知版權出處,若有侵(qin)權請來電盡刪(shan)!